Refine
Has Fulltext
- yes (14)
Is part of the Bibliography
- yes (14)
Document Type
- Journal article (14)
Language
- English (14)
Keywords
- echocardiography (5)
- prognosis (3)
- amyloidosis (2)
- cardiomyopathy (2)
- deformation (2)
- ejection fraction (2)
- Anderson-Fabry Disease (1)
- Cardiovascular magnetic-resonance (1)
- Chronic heart-failure (1)
- Coronary artery disease (1)
- D313Y genotype (1)
- Enzyme replacement therapy (1)
- Fabry cardiomyopathy (1)
- Fabry nephropathy (1)
- Fabry-associated pain (1)
- Guidelines (1)
- Hypertrophic cardiomyopathy (1)
- Impella (1)
- Management (1)
- Manifestation (1)
- Myocardial fibrosis (1)
- Non‐ischaemic cardiogenic shock (1)
- Prevalence (1)
- Prognostic impact (1)
- Risk-factors (1)
- Septal bulge (1)
- Task force (1)
- Valvular heart-desease (1)
- Ventricular-arrhythmias (1)
- alcohol (1)
- aneurysm (1)
- aortic valve stenosis (AS) (1)
- avascular necrosis (1)
- biomarker (1)
- blood pressure monitoring (1)
- bone (1)
- bull’s eye plot (1)
- calcium imaging (1)
- cardiac amyloidosis (1)
- cardiac transplantation (1)
- cardiovascular magnetic resonance (1)
- case report (1)
- chronic thromboembolic pulmonary hypertension (1)
- cigarette smoking (1)
- death rates (1)
- diagnostic medicine (1)
- diastolic dysfunction (1)
- dobutamine stress echocardiography (1)
- early-stage osteonecrosis (1)
- fabry disease (1)
- follow-up (1)
- heart disease (1)
- heart failure with mid-range ejection fraction (1)
- heart failure with reduced ejection fraction (1)
- hypertension (1)
- idiopathic osteonecrosis (1)
- implantation (1)
- inherited metabolic disorders (1)
- intake (1)
- left ventricular hypertrophy (1)
- left ventricular thrombusv (1)
- low-gradient AS (1)
- marrow (1)
- mild (1)
- mortality (1)
- myocardial infarction (1)
- myocardial fibrosis (1)
- nontraumatic osteonecrosis of the femoral head (1)
- occupational-status (1)
- prevalence (1)
- pseudo-severe AS (1)
- regression analysis (1)
- right ventricular dysfunction (1)
- risk factors (1)
- speckle tracking imaging (1)
- statins (1)
- stem cell transplantation (1)
- therapy (1)
- tricuspid pressure gradient (1)
- troponin T (1)
Institute
- Medizinische Klinik und Poliklinik I (13)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (6)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Medizinische Klinik und Poliklinik II (2)
- Institut für Pharmakologie und Toxikologie (1)
- Neurologische Klinik und Poliklinik (1)
- Pathologisches Institut (1)
High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease
(2016)
Background
High‐sensitivity troponin (hs‐TNT), a biomarker of myocardial damage, might be useful for assessing fibrosis in Fabry cardiomyopathy. We performed a prospective analysis of hs‐TNT as a biomarker for myocardial changes in Fabry patients and a retrospective longitudinal follow‐up study to assess longitudinal hs‐TNT changes relative to fibrosis and cardiomyopathy progression.
Methods and Results
For the prospective analysis, hs‐TNT from 75 consecutive patients with genetically confirmed Fabry disease was analyzed relative to typical Fabry‐associated echocardiographic findings and total myocardial fibrosis as measured by late gadolinium enhancement (LE) on magnetic resonance imaging. Longitudinal data (3.9±2.0 years), including hs‐TNT, LE, and echocardiographic findings from 58 Fabry patients, were retrospectively collected. Hs‐TNT level positively correlated with LE (linear correlation coefficient, 0.72; odds ratio, 32.81 [95% CI, 3.56–302.59]; P=0.002); patients with elevated baseline hs‐TNT (>14 ng/L) showed significantly increased LE (median: baseline, 1.9 [1.1–3.3] %; follow‐up, 3.2 [2.3–4.9] %; P<0.001) and slightly elevated hs‐TNT (baseline, 44.7 [30.1–65.3] ng/L; follow‐up, 49.1 [27.6–69.5] ng/L; P=0.116) during follow‐up. Left ventricular wall thickness and EF of patients with elevated hs‐TNT were decreased during follow‐up, indicating potential cardiomyopathy progression.
Conclusions
hs‐TNT is an accurate, easily accessible clinical blood biomarker for detecting replacement fibrosis in patients with Fabry disease and a qualified predictor of cardiomyopathy progression. Thus, hs‐TNT could be helpful for staging and follow‐up of Fabry patients.